News Briefing channel feed – Endpoints News

News Briefing channel feed

Akero, 89bio disclose public offerings; BioAge drops Phase 2 obesity drug

3 months ago

Allakos restructures after Phase 1 failure; AB2 inks deal with Nippon Shinyaku

3 months ago

Boehringer merges cancer vaccine and oncolytic virus teams; Dantari sells off assets

4 months ago

FDA delays decision on Stealth’s Barth syndrome drug; TargetRx raises $50M

4 months ago

Shanghai Bao, Sichuan Biokin file IPOs in Hong Kong; Disc's $200M offering

4 months ago

FDA puts Atara’s INDs on hold after rejection; Ascletis' safety data for obesity pill

4 months ago

WuXi AppTec sells medical device testing unit; Layoffs at Notch Therapeutics

4 months ago

Boehringer's schizophrenia asset fails Phase 3; GSK buys organoid biotech

4 months ago

Hinge Bio's $30M raise; Keros reports additional issues in Phase 2 PAH trial

4 months ago

Regeneron, Illumina invest in Truveta; Inhibrx Bio’s $150M loan

4 months ago

Immunovant’s $450M private placement; Biomea becomes an obesity biotech

4 months ago

Stemson Therapeutics shutters; Insilico teams up again with Menarini

4 months ago

Numab extends its Series C; AnaCardio raises $19M for its heart failure drug

4 months ago

Sana’s stock soars on new cell therapy data; UniQure’s $75M offering

4 months ago

Novo Nordisk partners with Variant Bio; Aviceda raises $207M in Series C

4 months ago

I-Mab stops work on CD73; Citius to pursue ‘strategic’ options

4 months ago

Hutchmed’s divestiture; Xgene reports Phase 2b win for non-opioid pain drug

4 months ago

Novartis ends Phase 1 radiopharma trial; Solve Therapeutics pursues $75M round

4 months ago

PDUFAs for Tonix and Nuvation; Sanofi vaccine partnership; RAPT allergy deal

5 months ago

Idorsia’s Tryvio deal delay; Galectin’s liver drug disappoints

5 months ago

Gilead deepens its stake in Assembly Biosciences; NGM licenses out MASH drug

5 months ago

Tessera gets up to $50M from the Gates Foundation; Tvardi’s reverse merger

5 months ago

Affimed’s early lung cancer data disappoint; Indapta's $22M round

5 months ago

Candid inks three T cell engager deals; PepGen trial put on hold

5 months ago

First page Previous page 1 2 345 6 7 Next page Last page